In colorectal cancer cells, IL-6 potentiates the Fra-1 activity by inducing the HDAC6-mediated Fra-1 deacetylation and accumulation (Figure 2B), resulting in the gain of stem-like features, partially dependent on the Fra-1-mediated transactivation of the NANOG promoter [48]. Here, IL6 is linked to colorectal cancer.